Foresight Biotherapeutics' Acquisition

Foresight Biotherapeutics was acquired by Shire on August 03, 2015.

Foresight Biotherapeutics is a clinical-stage drug development company developing therapies designed to address unmet needs in ophthalmology and otolaryngology. Foresight's platform Povidone-Iodine (P…

Articles about Foresight Biotherapeutics' Acquisition: